These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34914188)

  • 41. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent Advances in the Development of Pyrimidine-based CNS Agents.
    Pant S; Nain S
    Curr Drug Discov Technol; 2023; 20(2):e031022209428. PubMed ID: 36200187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: A review.
    Mermer A; Keles T; Sirin Y
    Bioorg Chem; 2021 Sep; 114():105076. PubMed ID: 34157555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
    Tian Y; Du D; Rai D; Wang L; Liu H; Zhan P; De Clercq E; Pannecouque C; Liu X
    Bioorg Med Chem; 2014 Apr; 22(7):2052-9. PubMed ID: 24631361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural and synthetic 5-(3'-indolyl)oxazoles: Biological activity, chemical synthesis and advanced molecules.
    Liu JR; Jiang EY; Sukhbaatar O; Zhang WH; Zhang MZ; Yang GF; Gu YC
    Med Res Rev; 2024 Aug; ():. PubMed ID: 39152525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for α-glucosidase.
    Yousefi R; Alavian-Mehr MM; Mokhtari F; Panahi F; Mehraban MH; Khalafi-Nezhad A
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1228-35. PubMed ID: 23043430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enaminonitrile in heterocyclic synthesis: synthesis and antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety.
    Bondock S; Fadaly W; Metwally MA
    Eur J Med Chem; 2009 Dec; 44(12):4813-8. PubMed ID: 19683840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
    Ali EMH; Abdel-Maksoud MS; Oh CH
    Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Azole-Pyrimidine Hybrid Anticancer Agents: A Review of Molecular Structure, Structure Activity Relationship, and Molecular Docking.
    Eze CC; Ezeokonkwo AM; Ugwu ID; Eze UF; Onyeyilim EL; Attah IS; Okonkwo IV
    Anticancer Agents Med Chem; 2022 Aug; 22(16):2822-2851. PubMed ID: 35306990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates.
    Islam F; Quadery TM
    Curr Drug Targets; 2021; 22(17):1944-1963. PubMed ID: 34042033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
    Abdallah AEM; Elgemeie GH
    Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Privileged substructure-based diversity-oriented synthesis pathway for diverse pyrimidine-embedded polyheterocycles.
    Kim H; Tung TT; Park SB
    Org Lett; 2013 Nov; 15(22):5814-7. PubMed ID: 24175659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in research of antitrypanosomal agents among synthetic heterocycles.
    Kryshchyshyn A; Kaminskyy D; Grellier P; Lesyk R
    Eur J Med Chem; 2014 Oct; 85():51-64. PubMed ID: 25072876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents.
    Abbas N; Matada GSP; Dhiwar PS; Patel S; Devasahayam G
    Anticancer Agents Med Chem; 2021; 21(7):861-893. PubMed ID: 32698738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microwave Induced Green Synthesis: Sustainable Technology for Efficient Development of Bioactive Pyrimidine Scaffolds.
    Sahoo BM; Banik BK; Kumar BVVR; Panda KC; Tiwari A; Tiwari V; Singh S; Kumar M
    Curr Med Chem; 2023; 30(9):1029-1059. PubMed ID: 35733315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single Heterocyclic Compounds as Monoamine Oxidase Inhibitors: From Past to Present.
    Wu SM; Qiu XY; Liu SJ; Sun J
    Mini Rev Med Chem; 2020; 20(10):908-920. PubMed ID: 32116191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medicinal significance of benzothiazole scaffold: an insight view.
    Sharma PC; Sinhmar A; Sharma A; Rajak H; Pathak DP
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):240-66. PubMed ID: 23030043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.